News & Analysis as of May 5, 2025

Today's Popular Updates

+ Follow

IP, Licensing, and M&A in the Life Sciences Industry: Trends to Watch in 2025

Morgan Lewis - As Prescribed on 1/20/2025

The life sciences industry has long been at the forefront of innovation, and 2025 promises to continue this trajectory with exciting developments in intellectual property (IP), licensing, and mergers and acquisitions (M&A)....more

Antitrust and Competition Life Sciences Quarterly Update Q2 2024

Goodwin on 9/10/2024

To date, 2024 has not yet seen the type of mega-merger (Pfizer/Seagen) or level of agency enforcement (Sanofi/Maze or Amgen/Horizon) as 2023. But two notable investigations — one still active — show the Federal Trade...more

Year-End Review of Key Trade Secret Decisions

Jones Day on 12/31/2019

A trade secret is any information used in one's business that derives independent economic value from being kept secret. Unlike patents, trade secrets are protected indefinitely for as long as they remain a secret. Due in...more

Emerging issues in the connected cars and autonomous vehicles market are influencing standard-essential patents and IP...

Hogan Lovells on 11/14/2017

In this hoganlovells.com interview, Hogan Lovells partner Celine Jimenez Crowson addresses the relationship between standard-essential patents (SEPs) and the connectivity technologies used in connected and autonomous vehicles...more

10 Key Intellectual Property Issues for M&A Deals

Holland & Knight LLP on 11/16/2016

Intellectual property (IP) issues are increasingly important factors in merger and acquisition (M&A) transactions. Of the various industry sector transactions included in recent American Bar Association (ABA) Business Law...more

5 Results

View per page